Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pai

Showing results (511-520 of 525) with videos related to

Pageof 53
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine gliomaAlberto Broniscer, Justin N Baker, Michael Tagen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2015
Needle(s) in the Haystack-Synchronous Multifocal Tumor-Induced OsteomalaciaAnand K Annamalai, Krishnaswamy Sampathkumar, Shubhada Kane, et al.
Practical Radiation Oncology|August 25, 2016
Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancerAvani D Rao, Elizabeth A Sugar, Daniel T Chang, et al.
Frontiers in Oncology|June 20, 2022
Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent ChemoradiotherapyAbhishek Mahajan, Ankur Chand, Ujjwal Agarwal, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 20, 2021
Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer PatientsSaranya Chumsri, Pooja P Advani, Tanmayi S Pai, et al.
Journal of Gastrointestinal Oncology|December 3, 2013
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutionsAaron T Wild, Susan M Hiniker, Daniel T Chang, et al.
Biomedicines|August 26, 2023
Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy-A Meta-AnalysisKarthik Nagaraja Rao, Prathamesh S Pai, Prajwal Dange, et al.
Oncotarget|February 18, 2020
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancerVanita Noronha, Vijay Maruti Patil, Amit Joshi, et al.
Annals of Surgery|June 11, 2020
Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care PolicyShailesh V Shrikhande, Prathmesh S Pai, Manish S Bhandare, et al.
Cancer|December 25, 2014
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinomaJoseph M Herman, Daniel T Chang, Karyn A Goodman, et al.
Pageof 53

Showing results (511-520 of 525) with videos related to

Sort By:
Pageof 53
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine gliomaAlberto Broniscer, Justin N Baker, Michael Tagen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2015
Needle(s) in the Haystack-Synchronous Multifocal Tumor-Induced OsteomalaciaAnand K Annamalai, Krishnaswamy Sampathkumar, Shubhada Kane, et al.
Practical Radiation Oncology|August 25, 2016
Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancerAvani D Rao, Elizabeth A Sugar, Daniel T Chang, et al.
Frontiers in Oncology|June 20, 2022
Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent ChemoradiotherapyAbhishek Mahajan, Ankur Chand, Ujjwal Agarwal, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 20, 2021
Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer PatientsSaranya Chumsri, Pooja P Advani, Tanmayi S Pai, et al.
Journal of Gastrointestinal Oncology|December 3, 2013
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutionsAaron T Wild, Susan M Hiniker, Daniel T Chang, et al.
Biomedicines|August 26, 2023
Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy-A Meta-AnalysisKarthik Nagaraja Rao, Prathamesh S Pai, Prajwal Dange, et al.
Oncotarget|February 18, 2020
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancerVanita Noronha, Vijay Maruti Patil, Amit Joshi, et al.
Annals of Surgery|June 11, 2020
Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care PolicyShailesh V Shrikhande, Prathmesh S Pai, Manish S Bhandare, et al.
Cancer|December 25, 2014
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinomaJoseph M Herman, Daniel T Chang, Karyn A Goodman, et al.
Pageof 53